長期投資家のためのIR情報
バリュートレンド

【4572】カルナバイオサイエンス
創薬支援。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2026.12 2026/08/06 Q2予 720 → 0.0% 0.0% -2,028 → 0.0% 0.0% -2,053 → 0.0% 0.0% -2,090 → 0.0% 0.0%
2026.12 2026/05/08 Q1予 720 → 0.0% 0.0% -2,028 → 0.0% 0.0% -2,053 → 0.0% 0.0% -2,090 → 0.0% 0.0%
2026.12 2026/02/10 当初予 720 - - - -2,028 - - - -2,053 - - - -2,090 - - -
2025.12 2026/02/10 実 579 ↑ +3.4% -19.8% -2,074 ↑ +2.8% +2.8% -2,144 ↑ +2.4% -0.3% -2,171 ↑ +2.3% -1.1%
2025.12 2025/12/18 修正予 560 ↓ -22.4% -22.4% -2,133 → 0.0% 0.0% -2,196 ↓ -2.8% -2.8% -2,223 ↓ -3.5% -3.5%
2025.12 2025/11/07 Q3予 722 → 0.0% 0.0% -2,133 → 0.0% 0.0% -2,137 → 0.0% 0.0% -2,147 → 0.0% 0.0%
2025.12 2025/08/06 Q2予 722 → 0.0% 0.0% -2,133 → 0.0% 0.0% -2,137 → 0.0% 0.0% -2,147 → 0.0% 0.0%
2025.12 2025/05/09 Q1予 722 → 0.0% 0.0% -2,133 → 0.0% 0.0% -2,137 → 0.0% 0.0% -2,147 → 0.0% 0.0%
2025.12 2025/02/10 当初予 722 - - - -2,133 - - - -2,137 - - - -2,147 - - -
2024.12 2025/02/10 実 636 ↑ +1.0% -31.2% -2,076 ↑ +3.6% +5.7% -2,080 ↑ +4.1% +5.5% -2,178 ↑ +0.1% +2.1%
2024.12 2024/12/19 修正予 630 ↓ -31.9% -31.9% -2,153 ↑ +2.2% +2.2% -2,168 ↑ +1.8% +1.5% -2,180 ↑ +2.0% +2.0%
2024.12 2024/11/08 Q3予 925 → 0.0% 0.0% -2,201 → 0.0% 0.0% -2,208 → 0.0% -0.3% -2,225 → 0.0% 0.0%
2024.12 2024/08/07 Q2予 925 → 0.0% 0.0% -2,201 → 0.0% 0.0% -2,208 → 0.0% -0.3% -2,225 → 0.0% 0.0%
2024.12 2024/05/10 Q1予 925 → 0.0% 0.0% -2,201 → 0.0% 0.0% -2,208 ↓ -0.3% -0.3% -2,225 → 0.0% 0.0%
2024.12 2024/02/09 当初予 925 - - - -2,201 - - - -2,201 - - - -2,225 - - -
2023.12 2024/02/09 実 1,625 ↑ +0.9% +80.2% -1,116 ↑ +5.7% +41.0% -1,126 ↑ +6.4% +40.4% -1,152 ↑ +6.3% +40.5%
2023.12 2023/12/14 修正予 1,610 ↑ +78.5% +78.5% -1,183 ↑ +37.4% +37.4% -1,203 ↑ +37.0% +36.3% -1,229 ↑ +36.5% +36.5%
2023.12 2023/11/07 Q3予 902 → 0.0% 0.0% -1,890 → 0.0% 0.0% -1,911 → 0.0% -1.1% -1,936 → 0.0% 0.0%
2023.12 2023/08/07 Q2予 902 → 0.0% 0.0% -1,890 → 0.0% 0.0% -1,911 → 0.0% -1.1% -1,936 → 0.0% 0.0%
2023.12 2023/05/10 Q1予 902 → 0.0% 0.0% -1,890 → 0.0% 0.0% -1,911 ↓ -1.1% -1.1% -1,936 → 0.0% 0.0%
2023.12 2023/02/10 当初予 902 - - - -1,890 - - - -1,890 - - - -1,936 - - -
2022.12 2023/02/10 実 1,386 ↑ +1.7% +23.0% -1,269 ↑ +12.5% +26.6% -1,278 ↑ +11.9% +26.1% -1,349 ↑ +10.8% +25.0%
2022.12 2022/12/14 修正予 1,363 ↑ +14.9% +20.9% -1,451 ↑ +13.2% +16.1% -1,451 ↑ +13.9% +16.1% -1,513 ↑ +13.0% +15.9%
2022.12 2022/11/07 Q3予 1,186 → 0.0% +5.2% -1,672 → 0.0% +3.4% -1,685 → 0.0% +2.6% -1,740 → 0.0% +3.3%
2022.12 2022/08/05 Q2予 1,186 → 0.0% +5.2% -1,672 → 0.0% +3.4% -1,685 → 0.0% +2.6% -1,740 → 0.0% +3.3%
2022.12 2022/05/10 Q1予 1,186 ↑ +5.2% +5.2% -1,672 ↑ +3.4% +3.4% -1,685 ↑ +2.6% +2.6% -1,740 ↑ +3.3% +3.3%
2022.12 2022/02/10 当初予 1,127 - - - -1,730 - - - -1,730 - - - -1,799 - - -
2021.12 2022/02/10 実 2,017 ↑ +0.5% +118.5% -531 ↑ +3.1% +70.7% -522 ↑ +5.4% +71.2% -534 ↑ +4.6% +70.7%
2021.12 2021/12/23 修正予 2,006 ↑ +117.3% +117.3% -548 ↑ +69.7% +69.7% -552 ↑ +69.6% +69.5% -560 ↑ +69.3% +69.3%
2021.12 2021/11/08 Q3予 923 → 0.0% 0.0% -1,811 → 0.0% 0.0% -1,816 → 0.0% -0.3% -1,825 → 0.0% 0.0%
2021.12 2021/08/06 Q2予 923 → 0.0% 0.0% -1,811 → 0.0% 0.0% -1,816 ↓ -0.3% -0.3% -1,825 → 0.0% 0.0%
2021.12 2021/05/10 Q1予 923 → 0.0% 0.0% -1,811 → 0.0% 0.0% -1,811 → 0.0% 0.0% -1,825 → 0.0% 0.0%
2021.12 2021/02/12 当初予 923 - - - -1,811 - - - -1,811 - - - -1,825 - - -
2020.12 2021/02/12 実 1,133 ↑ +2.7% +9.4% -1,057 ↑ +11.2% +40.6% -1,077 ↑ +10.4% +39.5% -1,111 ↑ +9.6% +39.0%
2020.12 2020/12/08 修正予 1,103 ↑ +6.5% +6.5% -1,190 ↑ +33.1% +33.1% -1,202 ↑ +33.0% +32.4% -1,229 ↑ +32.5% +32.5%
2020.12 2020/11/09 Q3予 1,036 → 0.0% 0.0% -1,779 → 0.0% 0.0% -1,794 → 0.0% -0.8% -1,822 → 0.0% 0.0%
2020.12 2020/08/07 Q2予 1,036 → 0.0% 0.0% -1,779 → 0.0% 0.0% -1,794 ↓ -0.8% -0.8% -1,822 → 0.0% 0.0%
2020.12 2020/05/12 Q1予 1,036 → 0.0% 0.0% -1,779 → 0.0% 0.0% -1,779 → 0.0% 0.0% -1,822 → 0.0% 0.0%
2020.12 2020/02/07 当初予 1,036 - - - -1,779 - - - -1,779 - - - -1,822 - - -
2019.12 2020/02/07 実 3,207 ↑ +0.0% +158.6% 977 ↑ +0.9% +158.9% 957 ↑ +0.6% +157.3% 828 ↑ +4.7% +148.9%
2019.12 2020/01/09 修正予 3,206 ↑ +5.5% +158.5% 968 ↑ +209.3% +158.4% 951 ↑ +240.9% +156.9% 791 ↑ +269.6% +146.7%
2019.12 2019/11/08 Q3予 3,038 → 0.0% +145.0% 313 → 0.0% +118.9% 279 → 0.0% +116.7% 214 → 0.0% +112.6%
2019.12 2019/08/13 Q2予 3,038 → 0.0% +145.0% 313 → 0.0% +118.9% 279 → 0.0% +116.7% 214 → 0.0% +112.6%
2019.12 2019/06/25 修正予 3,038 ↑ +145.0% +145.0% 313 ↑ +118.9% +118.9% 279 ↑ +116.8% +116.7% 214 ↑ +112.6% +112.6%
2019.12 2019/05/13 Q1予 1,240 → 0.0% 0.0% -1,658 → 0.0% 0.0% -1,658 ↑ +0.8% +0.8% -1,693 → 0.0% 0.0%
2019.12 2019/02/08 当初予 1,240 - - - -1,658 - - - -1,671 - - - -1,693 - - -
2018.12 2019/02/08 実 754 ↑ +0.1% -36.6% -1,144 ↓ -0.7% -68.5% -1,159 ↓ -0.6% -70.7% -1,210 ↓ -0.5% -59.6%
2018.12 2018/12/20 修正予 753 ↓ -36.7% -36.7% -1,136 ↓ -67.3% -67.3% -1,152 ↓ -66.0% -69.7% -1,204 ↓ -58.8% -58.8%
2018.12 2018/11/09 Q3予 1,190 → 0.0% 0.0% -679 → 0.0% 0.0% -694 → 0.0% -2.2% -758 → 0.0% 0.0%
2018.12 2018/08/06 Q2予 1,190 → 0.0% 0.0% -679 → 0.0% 0.0% -694 → 0.0% -2.2% -758 → 0.0% 0.0%
2018.12 2018/05/11 Q1予 1,190 → 0.0% 0.0% - - - - -694 ↓ -2.2% -2.2% -758 → 0.0% 0.0%
2018.12 2018/02/09 当初予 1,190 - - - -679 - - - -679 - - - -758 - - -
2017.12 2018/02/09 実 657 ↓ -6.3% -54.4% -699 ↑ +3.9% -1892.3% -711 ↑ +3.7% -1923.1% -737 ↑ +3.8% -12383.3%
2017.12 2017/11/10 Q3予 701 ↓ -51.3% -51.3% -727 ↓ -1964.1% -1964.1% -738 ↓ -2208.6% -1992.3% -766 ↓ -12866.7% -12866.7%
2017.12 2017/08/07 Q2予 1,440 → 0.0% 0.0% 39 → 0.0% 0.0% 35 ↓ -10.3% -10.3% 6 → 0.0% 0.0%
2017.12 2017/05/12 Q1予 1,440 → 0.0% 0.0% 39 → 0.0% 0.0% 39 → 0.0% 0.0% 6 → 0.0% 0.0%
2017.12 2017/02/10 当初予 1,440 - - - 39 - - - 39 - - - 6 - - -
2016.12 2017/02/10 実 811 ↑ +0.9% +0.9% -423 ↑ +2.1% +2.1% -440 ↑ +2.0% +2.0% -289 ↑ +3.3% +3.3%
2016.12 2016/12/16 当初予 804 - - - -432 - - - -449 - - - -299 - - -
2015.12 2016/02/12 実 1,569 ↑ +2.4% +2.4% 472 ↑ +26.9% +26.9% 492 ↑ +24.6% +24.6% 456 ↑ +25.3% +25.3%
2015.12 2015/11/06 Q3予 1,532 → 0.0% 0.0% 372 → 0.0% 0.0% 395 → 0.0% 0.0% 364 → 0.0% 0.0%
2015.12 2015/08/07 Q2予 1,532 → 0.0% 0.0% 372 → 0.0% 0.0% 395 → 0.0% 0.0% 364 → 0.0% 0.0%
2015.12 2015/07/28 当初予 1,532 - - - 372 - - - 395 - - - 364 - - -
2014.12 2015/02/13 実 - - - - - - - - - - - - - - - -
2014.12 2014/12/19 当初予 610 - - - -640 - - - -613 - - - -853 - - -
2013.12 2014/02/07 実 771 - - - -300 - - - -276 - - - -282 - - -
シェア ツイート
ページトップへ戻る